ArticleJournal for immunotherapy of cancer2020

Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity.

Adi Reches et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.